AAS
WST icon

Ameritas Advisory Services’s West Pharmaceutical WST Stock Holding History

Ameritas Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30
Closed -$6.6K – 2946
2025
Q2 		$6.6K Buy
+30
New +$6.41K ﹤0.01% 2156
2023
Q2 		– Sell
-4
Closed -$1.21K – 2532
2023
Q1 		$1.21K Buy
+4
New +$1.17K ﹤0.01% 2514

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Ameritas Advisory Services's WST Position: Q3 2025 in Review

Ameritas Advisory Services sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 30 shares — an estimated $6.6K sold.

Ameritas Advisory Services first reported a position in WST in Q1 2023 and held it in 2 quarters. The position peaked at $6.6K in Q2 2025. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Ameritas Advisory Services reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 30 West Pharmaceutical shares in Q3 2025, an estimated $6.6K.
  • Ameritas Advisory Services first reported a position in West Pharmaceutical in Q1 2023 and held it in 2 quarters.
  • Ameritas Advisory Services's West Pharmaceutical position peaked at $6.6K in Q2 2025.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.